IPO's: How Do They Work?

A beginners guide on Initial Public Offerings and How They Impact You

In partnership with

Smart Investors Are Betting On A.I. Stocks—Are You?

Experts say Trump’s $500B A.I. investment plan could transform the industry.

Meanwhile, a small but ambitious A.I. healthcare company just went public after eight years of innovation, securing $18M in funding and partnering with industry giants.

With a $120M market cap and shares still under $2, this stock may not stay cheap for long.

Welcome to The Profit Zone 👋

Where thousands of millionaires, CEO’s and high-performing entrepreneurs read the #1 financial newsletter on the web.

👉️ Retail Sales Are Down In January: What Does This Mean For You? 🤔 

👉️ IPOs: The Ins and Outs of IPOs and What You Should Know 📈 

👉️ The Profit Academy: Your Shortcut to Smarter Investing 🤑 

"In investing, what is comfortable is rarely profitable."

- Robert Arnott

Retail Sales are Down in January 📉 

Sales fell by 0.9% month over month in January to $723.9 billion, reversing the 0.7% increase that happened in December, with the majority coming from Christmas spending.

On a year-over-year basis, sales rose by 4.2%.

Core retail sales, which exclude autos and parts, dropped by 0.4% month over month, while sales excluding auto and gas declined by 0.5% month over month.

Motor vehicle and parts dealers saw a 6.4% year-over-year gain, and food service sales rose 5.4%.

This weaker than normal data suggests that consumers are being cautious about their spending but could aid in the support of Federal Reserve cuts, which could lead to a benefit in the stock marker short term.

With that being said, the market is overextended on a P/E basis, and stocks are trading at wild valuations.

I would caution investing in stocks trading at all time highs right now as we could see a correction in the coming months.

But that doesn’t mean don’t invest, it means that we should take the extra time to value the stocks we’re buying ensuring they’re trading at fair valuations.

IPOs - What are they and how do they work?

In the fast-paced world of entrepreneurship…

Where time is money and building a passive income source is the ultimate goal…

The allure of Initial Public Offerings (IPOs) is hard to resist.

Especially when it comes to achieving financial freedom, the key to taking care of your own and your family's financial concerns.

But what exactly is an IPO?

An Initial Public Offering is the process through which a private company becomes a public company by offering its shares to the public for the first time.

It's like the grand opening of a blockbuster movie but in the financial markets.

An IPO is a big step for a company as it provides the company with access to raising a lot of money.

This gives the company a greater ability to grow and expand.

The increased transparency and share listing credibility can also be a factor in helping it obtain better terms when seeking borrowed funds as well.

A company will consider going public once it reaches a private valuation of ~$1 billion, also known as “Unicorn Status”.

However, companies of all sizes can IPO provided they have strong fundamentals and meet listing requirements.

So how do companies IPO?

Think of it as a company's debut on the stock market.

The company hires investment banks, like Goldman Sachs or Morgan Stanley, to help determine the offering price, manage regulatory requirements, and sell shares to eager investors like yourself.

Now, the exciting part…

What are the potential rewards and risks?

When it comes to rewards, think of companies like Google and Facebook.

They were once IPOs and early investors saw huge returns as these companies continued to grow.

But like anything related to money and wealth, there are risks associated too.

For certain companies, the hype might not match the reality.

Which will make investors like you feel the burn of a poor IPO.

One thing we have to realize as investors is that many times the hype around an IPO is what drives the share price.

But like all good investors do, we have to understand the intrinsic value of the company before we invest in anything.

Make sure you do your due diligence.

Let's look at these 5 hot prospects that are set to IPO soon or have already IPO’d

1) APUS - Apimeds Pharmaceuticals US: Price $4 - $5 (Expected IPO Feb 21, 2025)

2) NNNN - Anbio Biotechnology: Price $5 - $6 (Expected IPO Feb 19, 2025)

3) AARD - Aardvark Therapeutics Inc.: Price $16 (IPO’d Feb 13, 2025)

4) XHLD - TEN Holdings Inc.: Price $6 (IPO’d Feb 13, 2025)

5) SAIL - SailPoint Inc.: Price $23 (IPO’d Feb 13, 2025)

Make sure you’re aware of the risks when investing in recently IPO’d companies.

Happy investing!

Alex (The Dividend Dominator)
Founder and CEO of Dividend Domination Inc.
Follow me on Twitter, Instagram and LinkedIn

Welcome to The Profit Academy – Your Shortcut to Smarter Investing! 📈

Tired of guessing in the stock market? Want to invest with confidence and see exactly where the smart money is going?

The Profit Academy gives you the edge you’ve been missing.

Here’s what you get inside:

 In-Depth Stock Analysis – Breakdowns of the best opportunities in the market as well as full earnings summaries of stocks we’re watching.
 Real-Time Buys & Sells – See exactly what I’m buying as it happens. All new buys and sells are posted in the community.
 Inside Look at My Portfolio – Get full transparency on where I’m investing my money and why.
 Direct Access to Me – Ask questions anytime and get real answers from yours truly.

The best part?

You get FREE access to The Profit Academy when you upgrade to premium. 

Stop guessing. Start investing smarter.

🔗 Join now and take control of your financial future! 

Click below to upgrade and join us inside The Profit Academy for less than what you’ll spend on lunch today.

When the community reaches 100 members, the price will be going up.

Also, enjoy a 14 day FREE trial when you upgrade so you can test the waters. Cancel any time.

Disclaimer: The publisher does not guarantee the accuracy or completeness of the information provided in this page. All statements and expressions herein are the sole opinion of the author or paid advertiser.

Dividend Domination Inc. is a publisher of financial information, not an investment advisor. We do not provide personalized or individualized investment advice or information that is tailored to the needs of any particular recipient.

THE INFORMATION CONTAINED ON THIS WEBSITE IS NOT AND SHOULD NOT BE CONSTRUED AS INVESTMENT ADVICE, AND DOES NOT PURPORT TO BE AND DOES NOT EXPRESS ANY OPINION AS TO THE PRICE AT WHICH THE SECURITIES OF ANY COMPANY MAY TRADE AT ANY TIME. THE INFORMATION AND OPINIONS PROVIDED HEREIN SHOULD NOT BE TAKEN AS SPECIFIC ADVICE ON THE MERITS OF ANY INVESTMENT DECISION. INVESTORS SHOULD MAKE THEIR OWN INVESTIGATION AND DECISIONS REGARDING THE PROSPECTS OF ANY COMPANY DISCUSSED HEREIN BASED ON SUCH INVESTORS’ OWN REVIEW OF PUBLICLY AVAILABLE INFORMATION AND SHOULD NOT RELY ON THE INFORMATION CONTAINED HEREIN.

Any projections, market outlooks or estimates herein are forward-looking statements and are inherently unreliable. They are based upon certain assumptions and should not be construed to be indicative of the actual events that will occur. Other events that were not taken into account may occur and may significantly affect the returns or performance of the securities discussed herein. The information provided herein is based on matters as they exist as of the date of preparation and not as of any future date, and the publisher undertakes no obligation to correct, update or revise the information in this document or to otherwise provide any additional material.

The publisher, its affiliates, and clients of the publisher or its affiliates may currently have long or short positions in the securities of the companies mentioned herein or may have such a position in the future (and therefore may profit from fluctuations in the trading price of the securities). To the extent such persons do have such positions, there is no guarantee that such persons will maintain such positions.

Neither the publisher nor any of its affiliates accept any liability whatsoever for any direct or consequential loss howsoever arising, directly or indirectly, from any use of the information contained herein.

By using the Site or any affiliated social media account, you are indicating your consent and agreement to this disclaimer and our terms of use. Unauthorized reproduction of this newsletter or its contents by photocopy, facsimile or any other means is illegal and punishable by law.

Reply

or to participate.